Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for CJEU referral
Fordham 32 (Report 1): Patents in Pharma Fordham 32 (Report 1): Patents in Pharma Reviewed by Annsley Merelle Ward on Thursday, April 24, 2025 Rating: 5
[UPDATE] IPKat/LSE Joint Event: The CJEU's billion-dollar questions - who gets a SEP licence and when should an injunction be granted? [UPDATE] IPKat/LSE Joint Event: The CJEU's billion-dollar questions - who gets a SEP licence and when should an injunction be granted? Reviewed by Annsley Merelle Ward on Thursday, April 15, 2021 Rating: 5
IPKat/LSE Joint Event: The CJEU's billion-dollar questions - who gets a SEP licence and when should an injunction be granted? IPKat/LSE Joint Event: The CJEU's billion-dollar questions - who gets a SEP licence and when should an injunction be granted? Reviewed by Annsley Merelle Ward on Thursday, April 01, 2021 Rating: 5
Article 3(a) just keeps on giving: AG Opinion in SPC referrals C-650/17 and C-114/18 Article 3(a) just keeps on giving: AG Opinion in SPC referrals C-650/17 and C-114/18 Reviewed by Dr Rose Hughes on Friday, September 13, 2019 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.